日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk and Management of Bowel Obstruction in Colorectal Cancer Patients Undergoing Immunotherapy: A Cross-Sectional Multicenter Study

结直肠癌患者接受免疫治疗期间肠梗阻的风险及管理:一项横断面多中心研究

Hong, Zhi-Gang; Xiao, Binyi; Zheng, Muxu; Yang, Wanjun; Zhu, Liangjun; Liang, Guodong; Luo, Yuhao; Tang, Jinghua; Mei, Weijian; Yu, Jie-Hai; Hou, Zhenlin; Wu, Xiaojun; Ding, Peirong; Jiang, Wu

Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study

新辅助放化疗联合信迪利单抗治疗PD-L1 TPS≥1%或CPS≥1的pMMR/MSS直肠癌患者:一项开放标签、前瞻性II期研究

Hou, Zhenlin; Liao, Leen; Xiao, Weiwei; Sui, Qiaoqi; Han, Kai; Xiao, Binyi; Li, Yuan; Mei, Weijian; Yu, Jiehai; Hong, Zhigang; Chen, Qichen; Song, Ruyue; Li, Dandan; Zhang, Xiaoshi; Wang, Qiaoxuan; Pan, Zhizhong; Jiang, Wu; Ding, Peirong

β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.

β-榄香烯通过靶向 N6AMT1 促进铁死亡,从而提高伊马替尼对胃肠道间质瘤的敏感性

Lan Jin, Zhang Weili, Zeng Kaixuan, Li Cong, He Jiahua, Li Xinyue, Yang Rong, Chi Jun, Hong Zhigang, Wang Weifeng, Zhou Chi, Xiao Binyi, Fan Wenhua, Lin Junzhong, Ou Qingjian, Fang Yujing, Pan Zhizhong, Peng Jianhong, Li Weihao, Wu Xiaojun

Development and validation of a logistic regression model for the diagnosis of colorectal cancer

建立和验证用于诊断结直肠癌的逻辑回归模型

Li, Cong; Zhang, Weili; Chen, Qichen; Xiao, Fei; Yang, Xia; Xiao, Binyi; Cheng, Yanshuang; Qin, Jiayi; Li, Xueying; Wan, Desen; Pan, Zhizhong; Peng, Jianhong; Wu, Xiaojun

Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis.

染色体不稳定性与结直肠癌肝转移切除术后贝伐单抗的预后和疗效相关

Li Weihao, Lan Jin, Zhou Chi, Yang Rong, Wang Jiayu, He Jiahua, Xiao Binyi, Ou Qingjian, Fang Yujing, Fan Wenhua, Lin Junzhong, Pan Zhizhong, Peng Jianhong, Wu Xiaojun

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

奥沙利铂辅助化疗对错配修复缺陷型高危II期结肠癌患者疗效的回顾性研究

Liao, Leen; Tang, Jinghua; Hong, Zhigang; Jiang, Wu; Li, Yuan; Kong, Lingheng; Han, Kai; Hou, Zhenlin; Zhang, Chenzhi; Zhou, Chi; Zhang, Linjie; Sui, Qiaoqi; Xiao, Binyi; Mei, Weijian; Yu, Jiehai; Yang, Wanjun; Pan, Zhizhong; Ding, Pei-Rong

Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review

新辅助免疫治疗后dMMR/MSI-H结直肠癌的非手术治疗:叙述性综述

Xiao, Binyi; Yu, Jiehai; Ding, Pei-Rong

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study

新辅助伊马替尼治疗局部晚期直肠胃肠道间质瘤患者的疗效和安全性:一项多中心队列研究

Li, Weihao; Li, Xinyue; Yu, Kun; Xiao, Binyi; Peng, Jianhong; Zhang, Rongxin; Zhang, Lingfang; Wang, Kun; Pan, Zhizhong; Li, Cong; Wu, Xiaojun

B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy

B2M 和 JAK1/2 突变的 MSI-H 结直肠癌可从抗 PD-1 治疗中获益

Zhang, Chenzhi; Li, Dandan; Xiao, Binyi; Zhou, Chi; Jiang, Wu; Tang, Jinghua; Li, Yuan; Zhang, Rongxin; Han, Kai; Hou, Zhenlin; Zhang, Linjie; Sui, Qiaoqi; Liao, Leen; Pan, Zhizhong; Zhang, Xiaoshi; Ding, Peirong

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

一种结合DNA倍性和肿瘤负荷评分的新型生物标志物对结直肠癌患者初始可切除肝转移的预后价值

Peng, Jianhong; Li, Weihao; Fan, Wenhua; Zhang, Rongxin; Li, Xinyue; Xiao, Binyi; Dong, Yuejin; Wan, Desen; Pan, Zhizhong; Lin, Junzhong; Wu, Xiaojun